According to the research report titled ‘Global Vitrectomy Devices Market Size study by Product (Vitrectomy Packs, Vitrectomy Machines, Microscopic Illumination Equipment, Surgical Instruments, and Others) and Application (Diabetic Retinopathy, Retinal Detachment, Epiretinal Membrane, Macular Hole, and Others (Eye Infections and Eye Injuries) and Regional Forecasts 2021-2027’, available with MarketStudyReport, global vitrectomy devices market was worth USD 1.1  billion in 2020 and is projected to be valued USD 1.7  billion by the end of the forecast period 2021-2027, registering a CAGR of 6.2% throughout.  
 

As per the findings of the report, increasing technological advancements in surgical equipment and growing geriatric population are the major driving forces of global vitrectomy devices market. Moreover, the ‘World Population Ageing’ report by the United Nations organization claims that the number of elderly people is expected to increase significantly, reaching over 2.1 billion by 2050.
 

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4339693/
 

Besides, surging usage of minimally invasive equipment and growing public awareness about cost-effective surgical treatment are likely to enhance the industry outlook throughout the projected period. However, lack of effective healthcare treatments and slow adoption of healthcare technology might hamper industry progress in the coming years.
 

For the unversed, vitrectomy is a surgical technique that removes vitreous gel from the eye and treats various retinal illnesses such as macular hole, diabetic retinopathy, and macula pucker. It is also employed for a variety of procedures, including scar tissue removal and repair of small holes or tears in the macula.
 

Worldwide vitrectomy devices market is categorized on the basis of product (vitrectomy packs, vitrectomy machines, surgical instruments, microscopic illumination equipment, and others) and application (diabetic retinopathy, macular hole, retinal detachment, epiretinal membrane, and others (eye infections and eye injuries).
 

From a regional perspective, as per the report, the market fragmentation comprises North America (U.S., Canada), Europe (UK, France, Germany, Spain, Italy, ROE), Asia Pacific (China, Japan, India, Australia, South Korea, RoAPAC), and Latin America (Mexico, Brazil).
 

North America accounts for a significant market share owing to high prevalence of diabetic retinopathy and expanding number of people suffering from other retinal issues. Meanwhile, Asia-Pacific industry is expected to grow substantially over the analysis period, attributable to rising healthcare expenditure on invasive surgical equipment.
 

With respect to competitive landscape, Bausch & Lomb Inc., Synergetics Inc., Iridex Corp., Alcon AG, Carl Zeiss Meditec AG, Leica Microsystems GmbH, Nidek Co. Ltd., Topcon Corp., Lumenis Ltd., and Wapco Holding Inc. are the major contenders in global vitrectomy devices industry.